These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27160756)

  • 1. Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications.
    Matsushita K
    Curr Pharm Des; 2016; 22(30):4629-4637. PubMed ID: 27160756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome.
    Du Y; Li X; Liu B
    Life Sci; 2014 Mar; 99(1-2):1-6. PubMed ID: 24140889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorenal Syndrome and Heart Failure-Challenges and Opportunities.
    Yogasundaram H; Chappell MC; Braam B; Oudit GY
    Can J Cardiol; 2019 Sep; 35(9):1208-1219. PubMed ID: 31300181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome.
    Clementi A; Virzì GM; Battaglia GG; Ronco C
    Cardiorenal Med; 2019; 9(5):265-273. PubMed ID: 31266023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.
    Napoli C; Casamassimi A; Crudele V; Infante T; Abbondanza C
    Future Cardiol; 2011 Jul; 7(4):485-97. PubMed ID: 21797745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Mehta RL; Rabb H; Shaw AD; Singbartl K; Ronco C; McCullough PA; Kellum JA
    Contrib Nephrol; 2013; 182():174-94. PubMed ID: 23689662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
    Giam B; Kaye DM; Rajapakse NW
    Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
    Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiorenal syndrome: a mutual approach to concomitant cardiac and renal failure.
    Ben-Shoshan J; Entin-Meer M; Guzner-Gur H; Keren G
    Isr Med Assoc J; 2012 Sep; 14(9):570-6. PubMed ID: 23101423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal Syndrome in Acute Kidney Injury.
    Di Lullo L; Reeves PB; Bellasi A; Ronco C
    Semin Nephrol; 2019 Jan; 39(1):31-40. PubMed ID: 30606406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
    Ronco C; Cicoira M; McCullough PA
    J Am Coll Cardiol; 2012 Sep; 60(12):1031-42. PubMed ID: 22840531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorenal syndrome in chronic kidney disease.
    Tsuruya K; Eriguchi M
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):154-62. PubMed ID: 25636143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
    Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
    Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?
    Rubattu S; Mennuni S; Testa M; Mennuni M; Pierelli G; Pagliaro B; Gabriele E; Coluccia R; Autore C; Volpe M
    Int J Mol Sci; 2013 Nov; 14(11):23011-32. PubMed ID: 24264044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal syndrome.
    Ronco C; Di Lullo L
    Heart Fail Clin; 2014 Apr; 10(2):251-80. PubMed ID: 24656104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatorenal syndrome and type 1 and 2 cardiorenal syndromes: distinct competing medical therapies applied to a similar background of vasomotor reactive nephropathy.
    De Vecchis R; Esposito C; Di Biase G; Ariano C
    Minerva Cardioangiol; 2014 Feb; 62(1):105-16. PubMed ID: 24500221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiorenal problem.
    Pollock E; Nowak A
    Swiss Med Wkly; 2014; 144():w14051. PubMed ID: 25473886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes.
    Cruz DN
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):56-66. PubMed ID: 23265597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms].
    Virzi' GM; de Cal M; Cruz DN; Bolin C; Vescovo G; Ronco C
    G Ital Nefrol; 2012; 29(6):690-8. PubMed ID: 23229667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.